Novartis AG (NVS)
NYSE: NVS · IEX Real-Time Price · USD
97.28
+2.16 (2.27%)
At close: Apr 23, 2024, 4:00 PM
97.29
+0.01 (0.01%)
After-hours: Apr 23, 2024, 7:15 PM EDT
Novartis AG Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Novartis AG stock have an average target of 114, which predicts an increase of 17.19% from the current stock price of 97.28.
Analyst Consensus: Hold
* Price targets were last updated on Feb 23, 2024.
Analyst Ratings
The average analyst rating for Novartis AG stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold Initiates $114 | Hold | Initiates | $114 | +17.19% | Feb 23, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $114 | Hold | Initiates | $114 | +17.19% | Jan 23, 2024 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Sep 25, 2023 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 9, 2022 |
| Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 6, 2021 |
Financial Forecast
Revenue This Year
49.09B
from 46.66B
Increased by 5.20%
Revenue Next Year
51.06B
from 49.09B
Increased by 4.02%
EPS This Year
7.19
from 7.10
Increased by 1.23%
EPS Next Year
7.90
from 7.19
Increased by 9.92%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 51.9B | 54.3B | 56.5B | 55.1B | 54.6B |
| Avg | 49.1B | 51.1B | 51.7B | 51.9B | 51.6B |
| Low | 46.1B | 46.8B | 47.1B | 48.4B | 48.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.3% | 10.7% | 10.7% | 6.6% | 5.1% |
| Avg | 5.2% | 4.0% | 1.3% | 0.4% | -0.6% |
| Low | -1.2% | -4.7% | -7.7% | -6.4% | -7.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.52 | 8.94 | 9.89 | 9.42 | 8.62 |
| Avg | 7.19 | 7.90 | 8.36 | 8.09 | 7.97 |
| Low | 5.06 | 5.41 | 7.12 | 6.86 | 7.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.0% | 24.4% | 25.2% | 12.7% | 6.6% |
| Avg | 1.2% | 9.9% | 5.8% | -3.3% | -1.4% |
| Low | -28.8% | -24.7% | -9.8% | -17.9% | -10.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.